Phibro Animal Health Corporation

PAHCNASDAQHealthcare● Active

$31.60

$-0.83(-2.56%)

Market Cap$1.3B

P/E Ratio—

52W High$60.08

52W Low$22.847

Avg Volume363K

Open$32.65

Beta0.46

Forecast Market Cap PE Ratio

Phibro Animal Health Corporation（PAHC）股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

pahc · 股价预测 · 14 位分析师（近3月）· FMP · 更新于 2026年5月7日

分析师评级与共识

基于过去 3 个月内 14 位华尔街分析师

Buy

14 位分析师

共识

评级分布

Strong Buy

Buy

Hold

Sell

Strong Sell

合计: 14 · 买入占比: 42.9%

12 个月目标价

High

$49.00

Consensus

$49.00

+55.4% upside

Low

$49.00

Median: $49 · Last Close: $31.54

Phibro Animal Health Corporation（PAHC）的分析师共识为 Buy，基于过去 3 个月内 14 位华尔街分析师的评级。PAHC 的 12 个月平均目标价为 $49.00，相对当前价 $31.54 代表 +55.4% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

分析师目标价覆盖不足，无法为该股票生成预测图表。

短期股价预测

算法生成 · 每日更新

Date	Predicted Price	Change	Min	Max
2026-06-09	$30.43	↓ 3.50%	$30.08	$30.78

1-day model range: $30.08–$30.78. Peak: $30.78 (-3.50%).

长期股价预测

年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031

Year	Low	Avg Price	High	Change
2027	$38	$41	$43	+29.5%
2028	$43	$47	$52	+50.5%
2029	$46	$52	$57	+63.9%
2030	$47	$54	$61	+71.9%
2031	$48	—	$64	+76.6%

Confidence:Medium

基于技术分析的股价预测

14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明

Market Sentiment

BEARISH

Based on 14 technical indicators

7%7%86%

1Buy

1Neutral

12Sell

RSI (14)39.4Neutral

MACDBEARISH

Refreshes daily from EOD close

Moving Averages · PAHC · Jun 8, 2026

Simple Moving Average (SMA)

MA 5$31.46BUY

MA 10$31.64SELL

MA 20$33.18SELL

MA 50$46.11SELL

MA 100$47.32SELL

MA 200$43.54SELL

Current $PAHC · Price above MA = BUY signal

Exponential Moving Average (EMA)

EMA 5$31.77SELL

EMA 10$32.26SELL

EMA 20$35.12SELL

EMA 50$41.70SELL

EMA 100$44.05SELL

EMA 200$41.83SELL

Current $PAHC · Price above MA = BUY signal

How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:

Date	Brokerage	Action	Rating
2026-05-14	Citigroup	Maintains	Neutral→Neutral
2025-11-07	JP Morgan	Maintains	Overweight→Overweight
2025-08-29	B of A Securities	Maintains	Underperform→Underperform
2025-07-07	JP Morgan	Upgrade ↑	Neutral→Overweight
2025-06-25	Morgan Stanley	Maintains	Equal Weight→Equal Weight
2025-05-08	Morgan Stanley	Maintains	Equal Weight→Equal Weight
2025-02-10	Barclays	Maintains	Underweight→Underweight
2024-12-17	Morgan Stanley	Maintains	Equal Weight→Equal Weight
2024-11-12	Barclays	Maintains	Underweight→Underweight
2024-08-30	B of A Securities	Maintains	Underperform→Underperform

Citigroup2026-05-14

Maintains

Neutral→Neutral

JP Morgan2025-11-07

Maintains

Overweight→Overweight

B of A Securities2025-08-29

Maintains

Underperform→Underperform

JP Morgan2025-07-07

Upgrade ↑

Neutral→Overweight

Morgan Stanley2025-06-25

Maintains

Equal Weight→Equal Weight

Morgan Stanley2025-05-08

Maintains

Equal Weight→Equal Weight

Barclays2025-02-10

Maintains

Underweight→Underweight

Morgan Stanley2024-12-17

Maintains

Equal Weight→Equal Weight

Barclays2024-11-12

Maintains

Underweight→Underweight

B of A Securities2024-08-30

Maintains

Underperform→Underperform

Wall Street analysts have recently issued updated ratings on Phibro Animal Health Corporation (PAHC) stock. Of the recent 58 rating actions, 5 were upgrades and 7 were downgrades. 14 analysts currently cover PAHC.

分析师推荐趋势

Buy ratings0 → 0

Hold ratings1 → 1

Sell ratings0 → 0

PAHC analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.

财务预测：EPS 与营收一致预期

Revenue This Year

$1.5B

↓ 6.4% YoY

Revenue Next Year

$1.5B

↑ 3.3% YoY

EPS This Year

$3.07

EPS Next Year

$3.34

↑ 8.8% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast PAHC EPS of $3.07 for the current fiscal year, based on estimates from 3 analysts. The PAHC revenue forecast is $1.5B for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

PAHC 股价预测由两类独立数据源支撑：来自 14 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。PAHC 的共识目标价为 $49.00（+55.4% 上行空间），分析师共识为 Buy。

PAHC 的短期预测（明日）为 $30.43（-3.50%）。 PAHC 对 2027 年的股价预测均值为 $41。 PAHC 对 2030 年的预测区间为 $47–$61。

Phibro Animal Health Corporation 在 NASDAQ 上市，代码 PAHC。PAHC 在 2027 年的整体展望偏积极，在覆盖分析师中约 43% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

PAHC 预测 · 8 个问题

根据 14 位华尔街分析师，PAHC 的 12 个月平均目标价为 $49.00，最高 $49.00、最低 $49.00。若有图表，中位目标价可在上方查看。相对当前价 $31.54，隐含约 +55.4% 的上行空间。

PAHC 目标价PAHC 分析师目标价PAHC 12个月目标价目标价 PAHC

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.